País: Kirguistán
Idioma: ruso
Fuente: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)
Софосбувир+Ледипасвир
SHROOQ PHARMACEUTICALS (PVT) LTD
J05AX65
Sofosbuvir+Ledipasvir
400 мг/90 мг
таблетки, покрытые пленочной оболочкой
№28
по рецепту
SHROOQ PHARMACEUTICALS (PVT) LTD (Пакистан)
Прочие противовирусные препараты
ПЖВЛС: нет
2016-10-26
YTBEPXTNAIO Hbrfi AupeKTop fo o0ecIIe II TEXHIIKII M r4HCTpyK Wfl rIO MEAI,IUI4HCKOMy IIPI{MEHEHI,ITO JIEKAPCTBEHHO| O CPENCTBA BAJINI{C fIJIIOC Topronoe Ha3BaHlre Ba,rArac llnroc/ Valdis Plus MexaynapoAHoe HerrareHToBaHHoe Ha3BaHIre Ile4unacnup +CoSoc6ynup JlercapcrneHHafl Sopnra Ta6,rerxu, noKplrrble ueuoquofi o6oloqxofi . Cocras: B rcaxlofi'ra6lerxe, norcprrroft nlenoquofi o6oroqxofi coAepxarcl4eficrnyroque BeilIecrBa: neAr4nacBup - 90 ltr, co$oc6yBl{p - 400 vr BcnouozamerbHue seu4ecm6a.'Mr,rrcpoxpucra,'IJurqecKas Ilennrcno3a (aBI4IIen pH 102),:raxro:a, HarpLIf, KpaxMaJr fruKorqr, creapar MafHr'I-fl . ITneHoquan o6ono.trca: Merorlr{Jr E-5 (rzgpoKcrrlpolunMerl4nueJlJlrolosa), Ir3onponllnoertfi crrr4pr. flSf:6000, creapar MafHLIt, AzoKcLIA TLrraHa (E-171), TaJrbK. O n u c a u u e : Ee,rrre, noKpbrrbre n,teuo.+rofi o6o,roqroli, upoAonfoearofi $opuu ra6:rerxra c rpaBl4poBanuofi HaArrrrcbro Shrooq sa oAHoti cropoHe 14 rnaAKlie c 4pyrofi cropoHbt. @apuarcoreparreBTlrqecKaq rpyflrra: flpo'rueoeupycHbre npetraparbr Anq cr4creMHoro nplIMeHeHI{x. llporunoBI,IpycHbIe npeilaparbl npsMofo Aeficrauq. Koa ATX .105AX65 Qapn'raroror-HrrecKoe 4eiicrnue Mexauusu deilcmaun JleAunaceup rBn.f,ercs uuru6uropoM Br{pyca renarr4ra C, eos4eficrByroull4M na NS5A-6e:ror< Brpyca rerrarura C, rcoropufi y.racrnyer B pennnKauun PHK r4 Bllcrynaer BaxHbIM 3neMeHToM Soplluponarinr o6,racru cKolreHr4q Br4pL{oHoB Brrpyca renarula C. B Hacrof,Ir{ee BpeMt noArBepAu-fb 6uoxnN,rr,r.lecx14r\a MerortoM r[axr uHrla6uponauux NS5A neAI4nacBVpoM orcyrcrByer, rrocKoJrbry NS5A ue o6:raAaer rpepnaeHrarueuofi $yHxuraefi. Jla6oparopurre eHuq r4ccreAoBaHH.s Ha rrpeAMeT onpeAeneHHq yciloBLrfr pe3l.icTeHTHocrII u [epeKpecTHoa pe3rrcreHTHocrll yKa3bIBaIor, qro JreAI4nacBI4p Bo3Aefi crnyer Ha N S 5 A' CoQoc6ynup qBnf,ercfl uHru6uroporu PHK-sasacuN{ofi ronl4Mepa3bl Bnpyca rellarl4ra C NS5B, seo6xoAl.rvr oit Atn pennnKaurru Br{pyca. Co$oc6ynrap rpeAcraBrqer co6ofi HyKneorI4AHoe rrponeKapcrBo, Koropoe B npouecce BHyrpI4KnerorlHoro uera6olu:tr,la o6pa:oeunaer Sapvarconor Leer el documento completo